| Group | Early cases | Late cases | p-value |
| Time period: | 1993-1996 | 2006-2011 |
|
| # Cancers | 106 | 69 |
|
| MSS | 91 (85.8) | 58 (84.1) |
|
| MSI-high | 15 (14.2) | 11 (15.9) | 0.40 |
| Methylated | 14 (93.3%) | 10 (90.9%) |
|
| Methylated and BRAF* mutated | 9 (64.3%) | 6 (60%) |
|
| Methylated and BRAF wild | 5 (35.7%) | 4 (40%) |
|
| Unmethylated and BRAF wild | 1 (6.7%) | 1 (9.1%) |
|